Akitomo Yokokawa

2PUBLICATIONS
1CO-AUTHORS
Metabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 01, 2026
Endogenous melatonin partial metabolic clearance as a potential endogenous marker of CYP1A2 activity.

|Feb 23, 2021
Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms.

Akitomo Yokokawa, Shun Kaneko, Sayuri Endo

Pageof 1

Frequent Collaborators

1 joint publications

Hiromi Shibasaki